PMCB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PharmaCyte Biotech Inc (PMCB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks significant positive catalysts, has bearish technical indicators, and weak financial performance. Additionally, there are no strong trading signals or recent news to support a buy decision.
The technical indicators show a bearish trend with SMA_200 > SMA_20 > SMA_5. The RSI is neutral at 29.248, and the MACD histogram is slightly positive at 0.00247 but contracting. The stock is trading below the pivot level of 0.696, with key support at 0.646 and resistance at 0.745.
NULL. No recent news, no significant insider or hedge fund activity, and no congress trading data available.
The financial performance is weak with no revenue growth, negative net income (-$8.42M), and negative EPS (-1.24). The stock has a bearish trend and lacks strong trading momentum.
In Q2 2026, the company reported no revenue growth (0% YoY), a net loss of $8.42M (up 184.45% YoY), and a negative EPS of -1.24 (up 217.95% YoY). Gross margin remains at 0%.
No analyst ratings or price target changes available for PMCB.
